CDRH Premarket Division Reviews Mulled By ODE Incoming Director Schultz

Incoming Office of Device Evaluation Director Daniel Schultz, MD, is considering quality reviews of CDRH's premarket programs in 2003

More from Archive

More from Medtech Insight